NYSE:GSK
GlaxoSmithKline Stock News
$39.75
+0.480 (+1.22%)
At Close: Apr 19, 2024
Why GSK (GSK) is a Top Value Stock for the Long-Term
10:46am, Wednesday, 17'th Apr 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GSK Announces FDA Acceptance of New Meningococcal Jab BLA
09:16am, Wednesday, 17'th Apr 2024
The approval of GSK's 5-in-1 meningococcal ABCWY vaccine candidate, MenABCWY, could provide the broadest meningococcal serogroup coverage and lead to simplified immunization.
GSK encouraged by Shingles and Gonorrhoea trials
04:11am, Wednesday, 17'th Apr 2024
GSK has delivered encouraging updates from ongoing trials of its vaccines for Shingles and Gonorrhoea. In the follow-up Zoster trial for the now on-sale Shingrix vaccine, efficacy was more than 80% fo
GSK says efficacy of its shingles vaccine remains high after years
02:20am, Wednesday, 17'th Apr 2024
British drugmaker GSK said on Wednesday long-term data showed that its blockbuster shingles vaccine, Shingrix, had 79.7% efficacy in participants aged 50 years and above, six to 11 years after vaccina
GSK (GSK) Rises But Trails Market: What Investors Should Know
06:56pm, Thursday, 11'th Apr 2024
GSK (GSK) closed at $40.80 in the latest trading session, marking a +0.27% move from the prior day.
GSK (GSK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
07:06pm, Friday, 05'th Apr 2024
GSK (GSK) concluded the recent trading session at $41.19, signifying a +0.81% move from its prior day's close.
GSK (GSK) Registers a Bigger Fall Than the Market: Important Facts to Note
07:21pm, Tuesday, 02'nd Apr 2024
GSK (GSK) concluded the recent trading session at $41.79, signifying a -1.49% move from its prior day's close.
GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 28'th Mar 2024
Recently, Zacks.com users have been paying close attention to Glaxo (GSK). This makes it worthwhile to examine what the stock has in store.
Here's Why GSK (GSK) Gained But Lagged the Market Today
07:05pm, Wednesday, 27'th Mar 2024
GSK (GSK) closed at $42.99 in the latest trading session, marking a +0.47% move from the prior day.
GSK or TECH: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 25'th Mar 2024
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Techne (TECH). But which of these two stocks is more attractive to value i
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
01:30pm, Thursday, 21'st Mar 2024
GSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month in the United States. The company intends to start this in 2025.
GSK to cap out-of-pocket inhaler costs in US
05:01pm, Wednesday, 20'th Mar 2024
British pharmaceutical giant GSK said on Wednesday it will cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines for eligible patients in the United St
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
12:46pm, Wednesday, 20'th Mar 2024
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
GSK (GSK) Increases Yet Falls Behind Market: What Investors Need to Know
07:05pm, Tuesday, 19'th Mar 2024
In the most recent trading session, GSK (GSK) closed at $42.32, indicating a +0.43% shift from the previous trading day.
Jemperli Cancer Drug: What To Know As GSK Says It Improves Survival For Uterine Cancer Patients
11:22am, Saturday, 16'th Mar 2024
Jemperli, a cancer drug manufactured by GlaxoSmithKline, improved survival for patients diagnosed with a form of uterine cancer by more than one year, the British drugmaker said Saturday, the latest f
